Yahoo India Web Search

Search results

    • Eisai and Bristol Myers cancel cancer ADC deal

      Eisai and Bristol Myers cancel cancer ADC deal

      BioPharma Dive· 12 hours ago

      The Japan-based drugmaker said its U.S. partner’s “portfolio prioritization efforts” led to the termination. It will refund part of an upfront payment.